We added global health care conglomerate Johnson & Johnson (NYSE: JNJ) to our Growth Portfolio eight years ago. Since then, it has returned more than 160% in dividends and share price appreciation. However, JNJ has been stagnant for the past eighteen months, slightly worse than the overall stock market. Weighing… Read More
Jim Pearce is the Chief Investment Strategist of Personal Finance, our flagship publication, and serves as Director of the Investing Daily Wealth Society. He is also the Director of Research at Investing Daily, overseeing the work of our entire analyst team. He began his career as a stockbroker in 1983 and over the years has managed client investment portfolios for major banks, brokerage firms and investment advisors. Jim has a BA in Business Management from The College of William & Mary, and a CFP from the College for Financial Planning.
Analyst Articles
A new law says the best interests of the client must supersede the financial interests of the person making the recommendation. Read More
Can this food company sustain momentum and dominate its market, or will competitors come along to eat its lunch? Read More
I have learned many valuable lessons about investing over the past four decades, but these three stand out as the most important. Read More
None of the top 10 companies in 2018 for revenues or profits were among the best performing stocks in 2018. Here are the lessons for investors. Read More
In response to new U.S. tariffs, China is threatening to restrict access to precious metals that many industries can't live without. Read More
The tariff slugfest with China won’t go on forever, and when it ends these three companies should rally strongly. Read More
The unintended consequences of approving medical marijuana in France could be considerably larger than in the U.S. or Canada. Read More
Any one of these red flags could strongly indicate that your investment is at risk of blowing up. Read More
Sellers of ILCDs claim they offer the best of both worlds. But like everything else in life, there are trade-offs involved. Read More